Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation
Open accessThe DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.
Abstract
Extracellular vesicles can cross the blood–brain barrier (BBB), but little is known about passage. Here, we used multiple-time regression analysis to examine the ability of 10 exosome populations derived from mouse, human, cancerous, and non-cancerous cell lines to cross the BBB. All crossed the BBB, but rates varied over 10-fold. Lipopolysaccharide (LPS), an activator of the innate immune system, enhanced uptake independently of BBB disruption for six exosomes and decreased uptake for one. Wheatgerm agglutinin (WGA) modulated transport of five exosome populations, suggesting passage by adsorptive transcytosis. Mannose 6-phosphate inhibited uptake of J774A.1, demonstrating that its BBB transporter is the mannose 6-phosphate receptor. Uptake rates, patterns, and effects of LPS or WGA were not predicted by exosome source (mouse vs. human) or cancer status of the cell lines. The cell surface proteins CD46, AVβ6, AVβ3, and ICAM-1 were variably expressed but not predictive of transport rate nor responses to LPS or WGA. A brain-to-blood efflux mechanism variably affected CNS retention and explains how CNS-derived exosomes enter blood. In summary, all exosomes tested here readily crossed the BBB, but at varying rates and by a variety of vesicular-mediated mechanisms involving specific transporters, adsorptive transcytosis, and a brain-to-blood efflux system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 On-bead flow cytometry of exosome populations isolated from supernatants of 4 different cell lines, captured on streptavidin beads coated with biotinylated anti-CD63 mAbs and stained with the labeled detection Abs specific for CD46, αVβ6, αVβ3 and ICAM1 as described in Methods. Data are relative fluorescence intensity (RFI) values calculated as mean fluorescence intensity (MFI) of an experimental sample/MFI of an isotype control Ab. [White peaks = experimental samples; hatched peaks = isotope controls]. Note that exosomes produced by non-malignant cells (HaCaT and primary T cells) appear to differ from exosomes produced by malignant cells by the absence of αVβ3 and lower expression levels of αVβ6. Representative results are from 1 to 3 detection experiments performed with each exosome population.](https://figures.cochat.ai/paper-figures/624d7ee716904379955ce30fbf39b5dc/transport-of-extracellular-vesicles-across-the-blood-brain-barrier-brain-figure-2.jpg)






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, EVs have inherent targeting capabilities and can cross the BBB, facilitating efficient delivery of therapeutic cargo to the CNS [54–57].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [57]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Brain-derived EVs have been found to harbor the ability to penetrate the BBB. This breakdown is crucial as it potentially allows for releasing these EVs into peripheral circulation [54–57].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [57]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“sEVs can cross the blood–brain barrier and deliver cargo with crucial roles in many neurological disorders [17–23].”
From Differential RNA packaging into small extracellular vesicles by neurons and astrocytes (2021) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Théry, C., Witwer, K. W., Aikawa, E., Alcaraz, M. J., Anderson, J. D., Andriantsitohaina, R., Antoniou, A., Arab, T., Archer, F., Atkin‐Smith, G. K., et al. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1535750 · Cited by 11,099 · cited 3×
“EVs we refer to as “exosomes” were isolated by mini-size exclusion chromatography (SEC) from supernatants of 10 different human or murine cell lines (Table 1) and characterized according to the Minimal Information for Studies of Extracellular Vesicles 2018 (MISEV2018) criteria [2], as is routinely done in our laborato…”
BackgroundMethodShedding light on the cell biology of extracellular vesicles
van Niel, G., D'Angelo, G., & Raposo, G. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.125 · Cited by 8,369 · cited 2×
“of parent cells, where they are formed by inverse membrane invagination as intraluminal vesicles inside multivesicular bodies (MVBs) [4].”
BackgroundExtracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099 · cited 1×
“Exosomes are a subset of small extracellular vesicles (EVs) that are produced by all normal and malignant cells and are present in all body fluids [1].”
BackgroundGraphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,567
Exosomes as drug delivery vehicles for Parkinson’s disease therapy
Haney, M. J., Klyachko, N. L., Zhao, Y., Gupta, R., Plotnikova, E. G., He, Z., Patel, T., Piroyan, A., Sokolsky, M., Kabanov, A. V., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.033 · Cited by 2,009 · cited 1×
“, drug-loaded exosomes enter the brain using the same mechanisms as those employed by the parent cells [12].”
BackgroundAbels, E. R., & Breakefield, X. O. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0366-z · Cited by 1,678 · cited 1×
“Among the various EVs, exosomes are sized at 30–150 nm in diameter and are of special interest because of their origin, their ability to freely circulate and infiltrate various tissues and their molecular content mirroring that of parental cells [3].”
BackgroundZhang, H., Freitas, D., Kim, H. S., Fabijanic, K., Li, Z., Chen, H., Mark, M. T., Molina, H., Martin, A. B., Bojmar, L., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0040-4 · Cited by 1,613 · cited 1×
“The orientation of surface proteins in exosome membranes resembles that in the cell membrane of parent cells [5].”
BackgroundExtracellular Vesicles: Unique Intercellular Delivery Vehicles
Maas, S. L. N., Breakefield, X. O., & Weaver, A. M. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.11.003 · Cited by 1,429 · cited 2×
“Exosomes serve as an intercellular communication system, shuttling messages between cells and also conveying peptides, proteins, and genetic materials from parental to recipient cells [6].”
BackgroundFrom blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery
Banks, W. A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.21 · Cited by 1,204
Self-citationPlasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease
Shi, M., Liu, C., Cook, T. J., Bullock, K. M., Zhao, Y., Ginghina, C., Li, Y., Aro, P., Dator, R., He, C., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1314-y · Cited by 676
Self-citation
Research works printed but not linked: 1
- Nicolini, M., and Zatta, P.F. (1994). Glycoconjugates and anionic sites in the blood-brain barrier. Glycobiology and the Brain, Pergamon Press.
Cited by
Items 401–500 of 569
Mitochondrial Transplantation Therapy for Ischemic Stroke: Progress and Challenges
Zhao, Z.-H., Yang, X.-L., Lu, Z., Li, T., Zhao, L.-L., Li, Y., Dang, M., Zhang, G.-L., Chen, K., & Fan, H. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01682-1 · Cited by 5
“The unique surface protein of EVs enables them to protect their cargo from systemic degradation and facilitates BBB traversal (Banks et al. 2020 ), which supports the efficient and precise transport of their contents to target cells (Murphy et al. 2019).”
Zhou, X., Wang, D., Deng, H., Guo, J., Chen, X., Lin, Z., Liu, B., Zhao, R., Gao, L., Yin, X., et al. (2026) · Research · doi:10.34133/research.1233 · Cited by 5
“Studies have shown that EVs play roles in physiological and pathological processes such as maintaining BBB homeostasis, regulating tumor dynamics, and modulating inflammatory responses [ 25 , 26 ].”
Cho, E., Lee, J., Kim, J., Choi, J., Kang, M., & Song, J. (2026) · Journal of Biological Engineering · doi:10.1186/s13036-026-00673-6 · Cited by 3
Diversity of Extracellular Vesicles (EV) in Plasma of Cancer Patients
Whiteside, T. L., & Ferrone, S. (2022) · Physiology · doi:10.5772/intechopen.101760 · Cited by 2
Self-citationThe Roads We Take: Cellular Targets and Pathways Leading Biologics Across the Blood–Brain Barrier
Baghirov, H. (2022) · Frontiers in Drug Delivery · doi:10.3389/fddev.2022.946045 · Cited by 2
“, 2009) or extracellular vesicles (EVs) (Wiklander et al., 2015; Banks et al., 2020)—have been shown to reach the brain; although the extent of this accumulation varies considerably, the percentage of the injected dose also has a different meaning in this scenario, at least for EVs because of their large loading capac…”
BackgroundAli, S., Mukherjee, S., Goel, D., Ghosh, A., & Faruq, M. (2023) · Springer eBooks · doi:10.1007/978-981-99-3848-3_10 · Cited by 2
Khosroshahi, P. A., & Ghanbari, M. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111081 · Cited by 6
Extracellular vesicles for delivering therapeutic agents in ischemia/reperfusion injury
Zhou, W., Jiang, X., & Gao, J. (2024) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2024.100965 · Cited by 7
Exosomes as nanocarrier for Neurotherapy: Journey from application to challenges
Ale, Y., & Nainwal, N. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106312 · Cited by 4
The Role of Cells in Encoding and Storing Information: A Narrative Review of Cellular Memory
Flores, A. I., & Liester, M. B. (2024) · Cureus · doi:10.7759/cureus.73063 · Cited by 8
“Exosomes can cross the blood-brain barrier (BBB) [101], and this passage occurs bidirectionally [102].”
Decoding Parkinson's disease: A multifaceted approach to diagnosis and biomarker discovery
Ragab, M. H., Soliman, A.-H., Shaltout, A. E.-R., El-Ramly, T. A., Morris, M., Mohamed, O. A. A., Ibrahim, R., & Dakhlaah, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00015-4 · Cited by 4
Whiteside, T. L., Sehra, S., Chadderton, T., Guha, M., Stubbs, M. C., Timmers, C. D., & Jackson, E. K. (2025) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2025.101052 · Cited by 3
Self-citationA preliminary proteomic analysis of tear fluid in patients with high myopia
Wang, D., Wang, C., Hu, Z., Su, Y., & Jia, Z. (2025) · BMC Ophthalmology · doi:10.1186/s12886-025-04129-1 · Cited by 2
Singh, A. M., White, C. M., Phillips, A., Crowe, L. P., Marti, R., Finnerty, M. C., Viana, M. P., Antoniades, W., Bartlett, M. G., Martinez, V., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-58290-8 · Cited by 3
Heale, K. A., Nath, S. C., & Rancourt, D. E. (2021) · Current Protocols · doi:10.1002/cpz1.230 · Cited by 2
“Through this investigation, they found marked differences in the ability of exosomes from different cells to cross this barrier (Banks et al., 2020).”
BackgroundInfluentialMethods and Protocols for Using Extracellular Vesicles as Delivery Vehicles in Neuronal Research
Vaidya, M., Sayeed, N., Hobson, C., Sreerama, S., Smith, J., Shah, R., & Sugaya, K. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3203-1_13 · Cited by 2
Sambur, D. B., Kalinina, O. V., Aquino, A. D., Tirikova, P. V., Migunova, M. А., Koroleva, E. E., Trulyov, A. S., Rubinstein, A., Kudryavtsev, I. V., & Головкин, А. С. (2024) · Нейрохимия · doi:10.31857/s1027813324010096 · Cited by 2
Yu, J., Chen, F., Xu, Y., Shi, K., Zhang, Z., Peng, Q., Xie, Z., Lu, J. N., Wu, H., Ma, Y., et al. (2021) · medRxiv · doi:10.1101/2021.04.19.21255653 · Cited by 3
Kulakauskienė, D., Narauskaitė, D., Gečys, D., Juknaitė, O., Jankauskaitė, L., Masaitytė, A., Šventoraitienė, J., Inokaitis, H., Miknienė, Z., Sadauskienė, I., et al. (2021) · Preprints.org · doi:10.20944/preprints202107.0356.v1 · Cited by 1
“Additionally, it was well established that exosomes can effectively cross the blood-brain barrier and carry endogenous material to the brain from the peripheral circulatory system [16,17].”
BackgroundTran, P. V., Liu, S. X., Harris, A. C., Maxim, Z. L., Munirathinam, M., Muelken, P., Javadova, N., Kruttiventi, S., Kling, P. J., Baack, M. L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.15.648967 · Cited by 2
Identification of extremely GC-rich micro RNAs for RT-qPCR data normalization in human plasma
Baumann, V., Athanasiou, A.-T., Faridani, O. R., Schwerdtfeger, A. R., Wallner, B., & Steinborn, R. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.1058668 · Cited by 2
“Features such as non-invasiveness, stability, and repeatability, combined with the ability of EV-shuttled miRNAs to cross the blood-brain barrier (Banks et al., 2020), makes circulating plasma/serum miRNAs an ideal diagnostic signature for brain-related contexts.”
BackgroundShe, P., Ao, X., Zhan, X., Zhou, W., Cheng, Y., Yang, H. J., Wu, S., Zhang, X., Peng, W., & Wang, J. (2024) · BME Horizon · doi:10.70401/bmeh.2024.124 · Cited by 4
Vancolen, S. Y., Chevin, M., Robaire, B., & Sébire, G. (2025) · Placenta · doi:10.1016/j.placenta.2025.01.008 · Cited by 3
Mohiyuddin, S., Dipankar, P., Robinson, B., Jeyabose, A., & Karthikeyan, J. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1599392 · Cited by 3
Jagan, A., Nishimura, Y., Donovan, T. F., & Burniston, J. G. (2025) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.70036 · Cited by 1
“The unique properties of EV, including their resistance to enzymatic degradation, ability to cross the blood-brain barrier, and traceability to their cell of origin, make them a promising source for TBI biomarkers [22, 23].”
Mayhew, M., Megram, O., Roshan, S., Smith, M. J., White, S., Wilson, P., Hunt, J. A., Girolamo, L. A. D., James, V. H., & Hunter, E. (2025) · Metabolomics · doi:10.1007/s11306-025-02386-1 · Cited by 7
“The presence of EVs in all biofluids, coupled with their ability to cross the blood–brain barrier, further advances their applications in diagnosis and longitudinal disease monitoring via liquid biopsy (Banks et al., 2020 ; Dardet et al., 2022 ; Kalluri & LeBleu, 2020 ).”
Evidence of emerging transcriptome mediators of Alzheimer's disease in canine cognitive dysfunction
Osburn, S. C., Easterday, D., McEntee, C. M., Latham, A. S., Lark, D. S., McGrath, S., Moreno, J. A., & LaRocca, T. J. (2025) · Brain Pathology · doi:10.1111/bpa.70062 · Cited by 1
“In the other direction (i.e., EVs crossing into the brain), even less is known, although several studies have demonstrated that EVs in circulation reach the brain [76, 77].”
Farmen, K., Mamand, D. R., Tofiño-Vian, M., Yfanti, G., Liang, X., Hou, V. W. Q., Hou, V., Andaloussi, S. E., Wiklander, O. P. B., & Iovino, F. (2026) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70369 · Cited by 1
Yoon, E., Jeong, J., Choi, Y., Kim, D. H., Kim, T. M., Choi, E.-K., Kim, Y.-B., & Park, D. (2025) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szaf071 · Cited by 1
Khan, S. A., Gangadaran, P., Tiwari, P., Rajendran, R. L., Jamal, A., Hattiwale, S. H., Anand, K., Jha, S. K., Hong, C. M., Ahn, B., et al. (2026) · World Journal of Stem Cells · doi:10.4252/wjsc.v18.i2.116184 · Cited by 1
Nencini, S., Pifferi, A., Passaponti, S., Severi, F. M., Bocchi, C., Canaletti, S., Romagnoli, R., Cresti, L., Ermini, L., & Ietta, F. (2026) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00312.2025 · Cited by 1
Li, Q., Xu, J., Ye, B., Jin, P., Ong, D. B., Mun, K. S., Geng, X., Tang, Y., & Phang, K. C. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112432 · Cited by 1
Dyndał, K., Pańczyszyn-Trzewik, P., Jakubowska, B., & Sowa-Kućma, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052449 · Cited by 2
“Importantly, their ability to cross the blood–brain barrier (BBB) has opened new possibilities for studying central nervous system (CNS) processes through minimally invasive peripheral sampling (e.g., blood or saliva) [24].”
Głuszko, A., Kania, D., Hong, C., Pietrowska, M., Conway, J. F., & Whiteside, T. L. (2026) · Cells · doi:10.3390/cells15060512 · Cited by 1
Self-citationCell-Derived Nanocarriers for Monocyte-Mediated Therapeutic Delivery: Concept and Challenges
Yu, S. E., Kim, J., & Sung, H. (2026) · Yonsei Medical Journal · doi:10.3349/ymj.2025.0286 · Cited by 1
“30,63 Pro-inflammatory cytokines disrupt the tight junctions of the BBB, with incremental paracellular permeability, 63 thereby enabling nanocarriers to pass into the brain parenchyma.”
Delbaz, A., & John, J. A. S. (2026) · Cells · doi:10.3390/cells15080690 · Cited by 2
Druszczyńska, M., Sadowska, B., Kulesza, J., Kulesza, E., & Fol, M. (2026) · Vaccines · doi:10.3390/vaccines14050412 · Cited by 2
“Illustration prepared based on information included in given references [22,23,30–36].”
Duan, J., Chen, J., Yu, B., Chang, J., Liang, X., Guan, X., & Guo, W. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.177052 · Cited by 3
Puthiyattil, N., Varughese, D., Mani, B. M., Babu, R. S., Nair, K. S., George, R. L., Ramitha, P. A., Dogra, N., Mathew, M., Varghese, M. T., et al. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103178 · Cited by 3
Citron, B. A., Murray, K. E., Lemenze, A. D., Mausoof, A. E., Beck, K. D., Velloso, F. J., Levison, S. W., & Delic, V. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1766698 · Cited by 2
“Exosomes have been shown to cross the blood–brain barrier (Banks et al., 2020) and likely do so during exercise; however, the rate at which they can cross the BBB and the length of time required to induce exercise-like changes are unknown.”
Yang, T., Canham, S., Kaserman, E., More, M., & Bai, S. (2026) · Journal of Microencapsulation · doi:10.1080/02652048.2026.2676311 · Cited by 1
“2017, Banks et al .”
Stein, J. B., Arif, M., Cheung, H., & Lee, K. (2026) · Cell Biomaterials · doi:10.1016/j.celbio.2026.100495 · Cited by 2
Zhou, Y., & Jiang, T. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1854892 · Cited by 1
Najjar, Y. G., Hong, C. S., Menshikova, E. V., Kirkwood, J. M., Diergaarde, B. B., Jackson, E. K., & Whiteside, T. L. (2026) · OncoImmunology · doi:10.1080/2162402x.2026.2688603 · Cited by 1
“21 TEX circulate freely in body fluids of cancer patients 22 and, as previously reported, can deliver CD39/CD73 or ADO to various immune and non-immune cells in the TME.”
Self-citationBreast milk exosomes: Implications for Brain function and Oncogenesis
Kosma, E., Vrachas, D., Rodoglou, P., Tsinoglou, M., Michopoulou, V., Papakonstantinou, E., Vlachakis, D. P., Adamopoulos, C., & Piperi, C. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106829 · Cited by 2
The nano-neuro nexus: smart sensors at the frontier of detecting neurodegeneration
Mehrotra, A., Sood, A., Yadav, S., Raval, A. D., Jyothi, S. R., Sah, A. K., Sharma, C., & Maharana, L. (2026) · Frontiers in Nanotechnology · doi:10.3389/fnano.2026.1843615 · Cited by 1
Yao, T., Li, L., Su, Y., Shao, W., Fan, F., Qiu, R., Liu, J., Xi, S., Cheng, Y., & Fu, Q. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106890 · Cited by 1
Exosome Biology at the Interface of Neurodegeneration and Therapeutic Innovation
Maity, D., Gowtham, A., Mishra, Y., & Kaundal, R. K. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06052-y · Cited by 2
“Upon contact with brain endothelial cells, circulating exosomes are taken up via endocytosis, macropinocytosis, or direct membrane fusion, enabling their entry into brain tissue [127].”
Sastrawidjaya, C., & Nguyen, P. H. D. (2023) · Journal of Extracellular Biology · doi:10.1002/jex2.99 · Cited by 2
Sambur, D. B., Kalinina, O. V., Aquino, A. D., Tirikova, P. V., Migunova, M. А., Koroleva, E. E., Trulioff, A. S., Rubinstein, A., Kudryavtsev, I. V., & Головкин, А. С. (2024) · Neurochemical Journal · doi:10.1134/s1819712424010197 · Cited by 1
Isolation and Identification of Brain Tissue Extracellular Vesicles for Translational Proteomics
Lihon, M. V., Tuchscherer, N. A., & Tao, W. A. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-4298-6_15 · Cited by 1
Prospects of Extracellular Vesicles in Otorhinolaryngology, Head and Neck Surgery
Sluga, M., Battelino, S., & Vozel, D. (2021) · Journal of Nanotheranostics · doi:10.3390/jnt2040013 · Cited by 1
“In investigations of the genetic manipulation of exosome secretion in tumoral cells, the RAB family have been proved to regulate exosome secretion [13].”
BackgroundApplication of Exosome-based Drug Delivery System in Combination Anticancer Treatment
Song, Y. (2023) · Journal of Korean Society of Health-System Pharmacists · doi:10.32429/jkshp.2023.40.2.006 · Cited by 1
Nath, S., Pountney, D. L., & Neužil, J. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1240959 · Cited by 1
“Research has also shown that exosomes released by BECs transfer specific cargo to recipient brain cells (Banks et al., 2020).”
BackgroundAdeno-associated viruses escort nanomaterials to specific cells and tissuesPreprint
Nagao, K., Paniagua, E. V., Lei, K., Beckham, J. L., Worthington, P., Manthey, M., Ye, M., Koehler, F., Kim, Y. J., Malkin, E., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.04.647267 · Cited by 2
“Numerous strategies have been explored to address this limitation, including grafting the delivery vehicles with poly(ethylene glycol) (PEG) and targeting moieties (e.g., antibodies, peptides) 8,16–20 , employing extracellular vesicles 21 , and engineering virus-like particles 22 .”
Yakovlev, A. A., Antonov, V. D., Druzhkova, T. A., Guekht, A. B., & Gulyaeva, N. V. (2021) · Biomedical Chemistry Research and Methods · doi:10.18097/bmcrm00148
Harrison, M. S., Driscoll, B. G., Farnsworth, J., Hinton, A. S., Peppi, M., McLean, W. J., & Parham, K. (2022) · Research Square · doi:10.21203/rs.3.rs-2038495/v1
Circulating cell-free mitochondria and membrane vesicles
Paley, E. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19122-0.00016-9
Luo, X., Jean‐Toussaint, R., Saçan, A., & Ajit, S. K. (2021) · Figshare · doi:10.6084/m9.figshare.14954702
Luo, X., Jean‐Toussaint, R., Saçan, A., & Ajit, S. K. (2021) · Figshare · doi:10.6084/m9.figshare.14954705
Luo, X., Jean‐Toussaint, R., Saçan, A., & Ajit, S. K. (2021) · Figshare · doi:10.6084/m9.figshare.14954708
Luo, X., Jean‐Toussaint, R., Saçan, A., & Ajit, S. K. (2021) · Figshare · doi:10.6084/m9.figshare.14954699
de Paula, G. C., Aldana, B. I., Battistella, R., Fernández‐Calle, R., Bjure, A., Lundgaard, I., Deierborg, T., & Duarte, J. M. N. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.04.587954
Хаспеков, Л. Г., & Yakovlev, A. A. (2023) · Нейрохимия · doi:10.31857/s1027813323010089 · Cited by 1
The molecular signature of Rett syndrome
Sangani, N. B. (2024) · Research Publications (Maastricht University) · doi:10.26481/dis.20240702ns
Advances in Research on the Mechanisms of Islet Amyloid Polypeptide in the Neurovascular Unit
徐, 畅. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1492432
The Role of Extracellular Vesicles in Inflammatory Bowel Diseases
Wei, X., & Cao, X. (2024) · Springer eBooks · doi:10.1007/978-981-97-5536-3_11
Whiteside, T. L. (2025) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2025.01.004
Self-citationMondal, S. K., Hong, C., Han, J., Diergaarde, B. B., Zandberg, D. P., & Whiteside, T. L. (2025) · Carcinogenesis · doi:10.1093/carcin/bgaf016 · Cited by 1
“Injected into mice, murine or human TEX circulate freely in plasma and body fluids crossing all tissue barriers (5,6).”
Self-citationXavier, G., Ota, V., Kajitani, G. S., Mauer, J., Asprino, P. F., Costa, G. O., Cavalcante, D. A., Cerqueira, R. O., Novaes, A., dos Santos, F., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5243800
ELTAHAN, M., Baker, D. H. A., Abbas, H. S., Abdelmonem, R., El-Nabarawi, M. A., & Attia, A. (2025) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2025v17i5.54735
Zhanina, M. Y., Druzhkova, T. A., Vladimirova, E. E., Guekht, A. B., & Gulyaeva, N. V. (2025) · Neurochemical Journal · doi:10.1134/s1819712425700539
D’Ambrosio, A., Zamboni, S., Camerini, S., Casella, M., Sanchez, M., Pietraforte, D., Vanacore, N., Diociauti, M., Altieri, M., Piero, V. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26945355
de Paula, G. C., Aldana, B., Battistella, R., Fernández‐Calle, R., Bjure, A., Lundgaard, I., Deierborg, T., & Duarte, J. M. N. (2024) · Figshare · doi:10.6084/m9.figshare.26750003
de Paula, G. C., Aldana, B., Battistella, R., Fernández‐Calle, R., Bjure, A., Lundgaard, I., Deierborg, T., & Duarte, J. M. N. (2024) · Figshare · doi:10.6084/m9.figshare.26750015
Togre, N. S., Mekala, N. K., Bhoj, P. S., Mogadala, N., Winfield, M., Trivedi, J., Grove, D., Kotnala, S., Rom, S., Sriram, U., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27129360
Togre, N. S., Mekala, N. K., Bhoj, P. S., Mogadala, N., Winfield, M., Trivedi, J., Grove, D., Kotnala, S., Rom, S., Sriram, U., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27129366
Togre, N. S., Mekala, N. K., Bhoj, P. S., Mogadala, N., Winfield, M., Trivedi, J., Grove, D., Kotnala, S., Rom, S., Sriram, U., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27129357
D’Ambrosio, A., Zamboni, S., Camerini, S., Casella, M., Sanchez, M., Pietraforte, D., Vanacore, N., Diociauti, M., Altieri, M., Piero, V. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26945343
de Paula, G. C., Aldana, B., Battistella, R., Fernández‐Calle, R., Bjure, A., Lundgaard, I., Deierborg, T., & Duarte, J. M. N. (2024) · Figshare · doi:10.6084/m9.figshare.26750006
D’Ambrosio, A., Zamboni, S., Camerini, S., Casella, M., Sanchez, M., Pietraforte, D., Vanacore, N., Diociauti, M., Altieri, M., Piero, V. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26945352
Togre, N. S., Mekala, N. K., Bhoj, P. S., Mogadala, N., Winfield, M., Trivedi, J., Grove, D., Kotnala, S., Rom, S., Sriram, U., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27129342
de Paula, G. C., Aldana, B., Battistella, R., Fernández‐Calle, R., Bjure, A., Lundgaard, I., Deierborg, T., & Duarte, J. M. N. (2024) · Figshare · doi:10.6084/m9.figshare.26750012
D’Ambrosio, A., Zamboni, S., Camerini, S., Casella, M., Sanchez, M., Pietraforte, D., Vanacore, N., Diociauti, M., Altieri, M., Piero, V. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26945370
D’Ambrosio, A., Zamboni, S., Camerini, S., Casella, M., Sanchez, M., Pietraforte, D., Vanacore, N., Diociauti, M., Altieri, M., Piero, V. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26945337
D’Ambrosio, A., Zamboni, S., Camerini, S., Casella, M., Sanchez, M., Pietraforte, D., Vanacore, N., Diociauti, M., Altieri, M., Piero, V. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26945346
Togre, N. S., Mekala, N. K., Bhoj, P. S., Mogadala, N., Winfield, M., Trivedi, J., Grove, D., Kotnala, S., Rom, S., Sriram, U., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27129345
D’Ambrosio, A., Zamboni, S., Camerini, S., Casella, M., Sanchez, M., Pietraforte, D., Vanacore, N., Diociauti, M., Altieri, M., Piero, V. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26945373
Togre, N. S., Mekala, N. K., Bhoj, P. S., Mogadala, N., Winfield, M., Trivedi, J., Grove, D., Kotnala, S., Rom, S., Sriram, U., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27129336
Singh, R., Rai, S., Bharti, P. S., Zehra, S., Gorai, P. K., Modi, G. P., Rani, N., Dev, K., Inampudi, K. K., Y., V. V., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26736822
D’Ambrosio, A., Zamboni, S., Camerini, S., Casella, M., Sanchez, M., Pietraforte, D., Vanacore, N., Diociauti, M., Altieri, M., Piero, V. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26945361
D’Ambrosio, A., Zamboni, S., Camerini, S., Casella, M., Sanchez, M., Pietraforte, D., Vanacore, N., Diociauti, M., Altieri, M., Piero, V. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26945328
Togre, N. S., Mekala, N. K., Bhoj, P. S., Mogadala, N., Winfield, M., Trivedi, J., Grove, D., Kotnala, S., Rom, S., Sriram, U., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27129348
D’Ambrosio, A., Zamboni, S., Camerini, S., Casella, M., Sanchez, M., Pietraforte, D., Vanacore, N., Diociauti, M., Altieri, M., Piero, V. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26945331
D’Ambrosio, A., Zamboni, S., Camerini, S., Casella, M., Sanchez, M., Pietraforte, D., Vanacore, N., Diociauti, M., Altieri, M., Piero, V. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26945358
D’Ambrosio, A., Zamboni, S., Camerini, S., Casella, M., Sanchez, M., Pietraforte, D., Vanacore, N., Diociauti, M., Altieri, M., Piero, V. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26945364
de Paula, G. C., Aldana, B., Battistella, R., Fernández‐Calle, R., Bjure, A., Lundgaard, I., Deierborg, T., & Duarte, J. M. N. (2024) · Figshare · doi:10.6084/m9.figshare.26750009
Luo, X., Jean‐Toussaint, R., Saçan, A., & Ajit, S. K. (2021) · Figshare · doi:10.6084/m9.figshare.14954696
Schenck, J. K., Karl, M. T., Paredes, C. C., Bastin, A., Pushkarsky, T., Břicháček, B., Miller, R. H., & Bukrinsky, M. (2024) · Figshare · doi:10.6084/m9.figshare.26719980
D’Ambrosio, A., Zamboni, S., Camerini, S., Casella, M., Sanchez, M., Pietraforte, D., Vanacore, N., Diociauti, M., Altieri, M., Piero, V. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26945367
Metadata
- Authors
- Banks, W. A., Sharma, P., Bullock, K. M., Hansen, K. M., Ludwig, N., & Whiteside, T. L.
- Affiliations
- University of Washington (US)
- University of Pittsburgh (US)
- Corresponding author
- Banks, William A.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-06-21
- Volume
- 21
- Issue
- 12
- Pages
- 4407
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7352415
- OpenAlex
- W3036596408
- Cited by
- 561
- References
- 57
- Citations by year
- 2026: 99 · 2025: 102 · 2024: 132 · 2023: 90 · 2022: 81 · 2021: 54 · 2020: 2
- FWCI
- 18.72
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institutes of Health (1RO1 AG046619)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- extracellular vesicles, exosomes, blood-brain barrier, BBB crossing, brain pharmacokinetics, lipopolysaccharide, inflammation, mannose 6-phosphate receptor, CD46, integrins, ICAM-1, vesicular transporters
- MeSH terms
- Animals, Biological Transport, Blood-Brain Barrier, Cell Line, Humans, Inflammation, Male, Cell Line, Tumor, Mice, Exosomes, Transcytosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.